http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1534398-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6eff2d87414496b09bb38a7357dff005 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4409 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 |
| filingDate | 1988-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1990-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37dc96059f6f66e10d00b98a32d9a277 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb6e0c5f51914dfce9627d4b903af6df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e40439d1130fb7a1f9b52e12a3dc95c5 |
| publicationDate | 1990-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SU-1534398-A1 |
| titleOfInvention | Method of treatment of tuberculosis of the lungs |
| abstract | This invention relates to phthisiology. The goal is to reduce the duration of treatment of pulmonary tuberculosis in patients with chronic alcoholism. The total antithyptic activity of the blood plasma is determined before and one hour after the intravenous administration of PASK and isoniazid. With a difference of 0.6 mg / ml and more, PASK and isoniazid are further treated, and with a difference of less than 0.6 mg / ml, isoniazid and ethionamide are treated. |
| priorityDate | 1988-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.